BOLT vs J · rev $7.7M vs P/E 36, $14.40B cap
Bolt Biotherapeutics (BOLT) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
J does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the BOLT and J stock pages for the full models.
Not investment advice.